Results of CRU assays of cells from secondary cultures of lin− CB cells
Experiment no. . | SF/TPO . | SF/TPO + SDF-1 . | SF/TPO + TGF-β1 . | SF/TPO + SDF-1 + TGF-β1 . | 5 GFs* . | |||||
---|---|---|---|---|---|---|---|---|---|---|
Cells per mouse, × 106 . | L+ + M+ . | Cells per mouse, × 106 . | L+ + M+ . | Cells per mouse, × 106 . | L+ + M+ . | Cells per mouse, × 106 . | L+ + M+ . | Cells per mouse, × 106 . | L+ + M+ . | |
1 | 1.3 | 5/6 | 1.3 | 6/6 | 1.3 | 6/6 | 1.3 | 5/6 | 1.3 | 6/6 |
0.3 | 3/6 | 0.3 | 4/6 | 0.3 | 4/6 | 0.3 | 4/6 | 0.3 | 2/6 | |
2 | 1.0 | 5/6 | 1.0 | 6/6 | 1.0 | 5/6 | 1.0 | 5/6 | 1.0 | 5/6 |
0.4 | 1/6 | 0.4 | 3/6 | 0.4 | 1/5 | 0.4 | 1/6 | 0.4 | 3/6 | |
3 | 2.0 | 6/6 | 2.0 | 5/5 | 2.0 | 6/6 | 2.0 | 6/6 | 2.0 | 6/6 |
0.4 | 5/6 | 0.4 | 3/3 | 0.4 | 2/4 | 0.4 | 2/6 | 0.4 | 2/6 | |
CRUs per 106 input cells in second cultures (range defined by SEM) | 2.0 (1.6-2.6) | 4.6 (3.4-6.2) | 2.3 (1.8-3.0) | 1.7 (1.3-2.2) | 2.0 (1.5-2.5) |
Experiment no. . | SF/TPO . | SF/TPO + SDF-1 . | SF/TPO + TGF-β1 . | SF/TPO + SDF-1 + TGF-β1 . | 5 GFs* . | |||||
---|---|---|---|---|---|---|---|---|---|---|
Cells per mouse, × 106 . | L+ + M+ . | Cells per mouse, × 106 . | L+ + M+ . | Cells per mouse, × 106 . | L+ + M+ . | Cells per mouse, × 106 . | L+ + M+ . | Cells per mouse, × 106 . | L+ + M+ . | |
1 | 1.3 | 5/6 | 1.3 | 6/6 | 1.3 | 6/6 | 1.3 | 5/6 | 1.3 | 6/6 |
0.3 | 3/6 | 0.3 | 4/6 | 0.3 | 4/6 | 0.3 | 4/6 | 0.3 | 2/6 | |
2 | 1.0 | 5/6 | 1.0 | 6/6 | 1.0 | 5/6 | 1.0 | 5/6 | 1.0 | 5/6 |
0.4 | 1/6 | 0.4 | 3/6 | 0.4 | 1/5 | 0.4 | 1/6 | 0.4 | 3/6 | |
3 | 2.0 | 6/6 | 2.0 | 5/5 | 2.0 | 6/6 | 2.0 | 6/6 | 2.0 | 6/6 |
0.4 | 5/6 | 0.4 | 3/3 | 0.4 | 2/4 | 0.4 | 2/6 | 0.4 | 2/6 | |
CRUs per 106 input cells in second cultures (range defined by SEM) | 2.0 (1.6-2.6) | 4.6 (3.4-6.2) | 2.3 (1.8-3.0) | 1.7 (1.3-2.2) | 2.0 (1.5-2.5) |
In each of the 3 experiments performed, more than 90% of all the cells from each culture were injected at the doses shown into a minimum of 8 irradiated NOD/SCID mice. L+ indicates lymphoid engraftment with human cells (CD34−CD19/20+); M+, myeloid engraftment with human cells (CD45/71+CD15/66b+)
The 5 GFs were Flt3 ligand, SF, interleukin-3, interleukin-6, and granulocyte colony-stimulating factor, as described in “Materials and methods.”